Form 990 for tax year 2025
Filed by PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY.
Totals
- Total revenue
- $180,131,815
- Total expenses
- $53,795,577
- Contributions and grants received
- $175,140,008
- Grants paid
- $3,623,255
- Program service revenue
- $1,240,750
- Investment income
- $3,466,352
- Other revenue
- $284,705
- Total assets, end of year
- $285,156,429
- Total liabilities, end of year
- $8,671,312
- Net assets or fund balances, end of year
- $276,485,117
- Program services expenses (Part IX)
- $46,776,153
- Management and general expenses
- $6,552,383
- Fundraising expenses
- $467,041
- Program service expenses (Part III)
- $46,776,153
Program services were 87.0% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1c · Fundraising events
$2,491,522
-
1f · All other contributions, gifts and grants
$172,648,486
-
2a · Program service revenue: LICENSE FEES
total $40,750 · related or exempt $40,750
-
2b · Program service revenue: CONSULTING REV.
total $1,200,000 · related or exempt $1,200,000
-
3 · Investment income
total $3,465,310 · excluded $3,465,310
-
4 · Income from investment of tax-exempt bond proceeds
total $0
-
5 · Royalties
total $284,705 · excluded $284,705
-
6c · Rental income or loss
real property $0 · personal property $0
-
6d · Net rental income or loss
total $0
-
7a · Gross sales of assets other than inventory
securities $1,042
-
7c · Gain or loss
securities $1,042
-
7d · Net gain or loss
total $1,042 · excluded $1,042
-
8a · Fundraising events: gross income
$0
-
8a · Fundraising events: contributions included on line 1c
$2,491,522
-
8b · Fundraising events: direct expenses
$0
-
8c · Net income from fundraising events
total $0
-
9a · Gaming: gross income
$0
-
9b · Gaming: direct expenses
$0
-
9c · Net income from gaming
total $0
-
10a · Gross sales of inventory
$0
-
10b · Cost of goods sold
$0
-
10c · Net income from sales of inventory
total $0
-
11e · Other revenue, total
$0
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $3,373,255 · program services $3,373,255
-
2 · Grants to domestic individuals
total $0
-
3 · Grants to foreign organizations and individuals
total $250,000 · program services $250,000
-
4 · Benefits paid to or for members
total $0
-
5 · Compensation of officers, directors and key employees
total $2,707,897 · program services $1,270,723 · management and general $1,363,703 · fundraising $73,471
-
6 · Compensation of disqualified persons
total $0
-
7 · Other salaries and wages
total $6,961,962 · program services $4,492,490 · management and general $2,272,029 · fundraising $197,443
-
8 · Pension plan contributions
total $133,273 · program services $81,614 · management and general $48,235 · fundraising $3,424
-
9 · Other employee benefits
total $971,268 · program services $587,619 · management and general $375,715 · fundraising $7,934
-
10 · Payroll taxes
total $414,163 · program services $261,120 · management and general $145,719 · fundraising $7,324
-
11a · Fees: management
total $0
-
11b · Fees: legal
total $3,245,104 · program services $3,122,456 · management and general $122,648 · fundraising $0
-
11c · Fees: accounting
total $379,762 · program services $0 · management and general $379,762 · fundraising $0
-
11d · Fees: lobbying
total $0
-
11e · Fees: professional fundraising services
total $0
-
11f · Fees: investment management
total $0
-
11g · Fees: other
total $1,477,419 · program services $1,147,470 · management and general $235,838 · fundraising $94,111
-
12 · Advertising and promotion
total $60,914 · program services $567 · management and general $59,975 · fundraising $372
-
13 · Office expenses
total $142,690 · program services $76,848 · management and general $63,850 · fundraising $1,992
-
14 · Information technology
total $361,615 · program services $267,161 · management and general $85,718 · fundraising $8,736
-
15 · Royalties
total $0
-
16 · Occupancy
total $1,617,210 · program services $921,810 · management and general $663,056 · fundraising $32,344
-
17 · Travel
total $804,068 · program services $610,010 · management and general $185,086 · fundraising $8,972
-
18 · Travel or entertainment for public officials
total $0
-
19 · Conferences, conventions and meetings
total $3,550,707 · program services $3,544,219 · management and general $4,600 · fundraising $1,888
-
20 · Interest
total $0
-
21 · Payments to affiliates
total $0
-
22 · Depreciation, depletion and amortization
total $0
-
23 · Insurance
total $165,194 · program services $7,223 · management and general $157,971 · fundraising $0
-
24a · Other expenses: COLLABORATIVE RESEARCH PROG.
total $21,015,152 · program services $21,015,152 · management and general $0 · fundraising $0
-
24b · Other expenses: PATENT & LICENSE EXPENSE
total $4,125,033 · program services $4,125,033 · management and general $0 · fundraising $0
-
24c · Other expenses: INSTITUTION STAFF SUPPORT
total $1,423,770 · program services $1,423,770 · management and general $0 · fundraising $0
-
24d · Other expenses: RECRUITING
total $304,324 · program services $0 · management and general $304,324 · fundraising $0
-
24e · All other expenses
total $310,797 · program services $197,613 · management and general $84,154 · fundraising $29,030
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $682,163 · end of year $552,055
-
2 · Savings and temporary cash investments
beginning of year $27,944,828 · end of year $37,003,694
-
3 · Pledges and grants receivable
beginning of year $0 · end of year $0
-
4 · Accounts receivable
beginning of year $1,956,768 · end of year $26,854,850
-
5 · Loans and receivables from officers and key people
beginning of year $713,816 · end of year $662,829
-
6 · Loans and receivables from disqualified persons
beginning of year $0 · end of year $0
-
7 · Other notes and loans receivable
beginning of year $400,000 · end of year $418,530
-
8 · Inventories for sale or use
beginning of year $0 · end of year $0
-
9 · Prepaid expenses and deferred charges
beginning of year $2,610,092 · end of year $2,958,586
-
10a · Land, buildings and equipment: cost or other basis
$7,901,030
-
10b · Land, buildings and equipment: accumulated depreciation
$7,901,030
-
10c · Land, buildings and equipment, net
beginning of year $295,000 · end of year $0
-
11 · Investments: publicly traded securities
beginning of year $0 · end of year $0
-
12 · Investments: other securities
beginning of year $51,705,196 · end of year $54,432,280
-
13 · Investments: program-related
beginning of year $136,078,266 · end of year $161,974,562
-
14 · Intangible assets
beginning of year $0 · end of year $0
-
15 · Other assets
beginning of year $1,484,525 · end of year $299,043
-
17 · Accounts payable and accrued expenses
beginning of year $7,876,148 · end of year $8,351,742
-
18 · Grants payable
beginning of year $0 · end of year $0
-
19 · Deferred revenue
beginning of year $0 · end of year $0
-
20 · Tax-exempt bond liabilities
beginning of year $0 · end of year $0
-
21 · Escrow or custodial account liability
beginning of year $0 · end of year $0
-
22 · Loans and payables to officers and key people
beginning of year $0 · end of year $0
-
23 · Secured mortgages and notes payable
beginning of year $0 · end of year $0
-
24 · Unsecured notes and loans payable
beginning of year $0 · end of year $0
-
25 · Other liabilities
beginning of year $30,556,068 · end of year $319,570
-
27 · Net assets without donor restrictions
beginning of year $174,101,042 · end of year $243,998,841
-
28 · Net assets with donor restrictions
beginning of year $11,337,396 · end of year $32,486,276
Mission and programs · 2025
Mission
THE PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY'S (PICI) MISSION IS TO DEVELOP AND ACCELERATE ACCESS TO BREAKTHROUGH CANCER THERAPIES, CURATING INNOVATION FROM DISCOVERY TO PATIENT ACCESS.
Activities or mission (Part I)
SEE SCHEDULE O
-
PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY (PICI) ENCOURAGES ADVANCES IN CANCER IMMUNOTHERAPY RESEARCH, COLLABORATION, AND DISCOVERY, AND THE TRANSLATION OF THESE ADVANCES INTO CURES AND TREATMENTS FOR THE BENEFIT OF PATIENTS. TO DO THIS, PICI PARTNERS WITH ITS CONSORTIUM OF PREEMINENT HOSPITALS AND ACADEMIC RESEARCH CENTERS TO CONDUCT ITS DISCOVERY AND CLINICAL RESEARCH AND PROVIDES ITS PARTNERS WITH SHARED RESEARCH RESOURCES, SUCH AS SCIENTIFIC EQUIPMENT, CONSUMABLES, BIOINFORMATICS ANALYSIS, AND A SPECIMEN BIOBANK. PICI ALSO FUNDS AND OTHERWISE SUPPORTS CANCER IMMUNOTHERAPY RESEARCH WITHIN ITS CONSORTIUM.
Expenses $46,776,153 · Grants $3,623,255 · Revenue $1,240,750
As filed on the 2025 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
Tarak ModyTARAK MODY
CHIEF BUSINESS OFF. THRU 8/25
- Total calculated
- $886,463
- From this org
- $791,771
- From related orgs
- $0
- Other
- $94,692
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $391,895
- Bonus
- $0
- Other
- $399,876
- Deferred
- $30,854
- Nontaxable benefits
- $63,838
- Filer's total
- $886,463
-
John Connolly PhDJOHN CONNOLLY PHD
CHIEF SCIENTIFIC OFFICER
- Total calculated
- $778,175
- From this org
- $703,149
- From related orgs
- $0
- Other
- $75,026
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $624,119
- Bonus
- $0
- Other
- $79,030
- Deferred
- $10,500
- Nontaxable benefits
- $64,526
- Filer's total
- $778,175
-
Karen E Knudsen CostelloKAREN E KNUDSEN COSTELLO
CEO AS OF 03/2025
- Total calculated
- $714,456
- From this org
- $655,478
- From related orgs
- $0
- Other
- $58,978
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $604,600
- Bonus
- $50,000
- Other
- $878
- Deferred
- $10,500
- Nontaxable benefits
- $48,478
- Filer's total
- $714,456
-
Kevin MarksKEVIN MARKS
CHIEF LEGAL OFFICER
- Total calculated
- $698,463
- From this org
- $623,269
- From related orgs
- $0
- Other
- $75,194
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $622,099
- Bonus
- $0
- Other
- $1,170
- Deferred
- $10,500
- Nontaxable benefits
- $64,694
- Filer's total
- $698,463
-
Chris Cabanski Thru 1225CHRIS CABANSKI THRU 1225
SR DIR, NETWORK CLIN. RESEARCH
- Total calculated
- $514,939
- From this org
- $314,624
- From related orgs
- $0
- Other
- $200,315
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $313,483
- Bonus
- $0
- Other
- $1,141
- Deferred
- $155,308
- Nontaxable benefits
- $45,007
- Filer's total
- $514,939
-
Sara CoblinSARA COBLIN
SR VP FINANCE & ADMIN.
- Total calculated
- $496,550
- From this org
- $444,632
- From related orgs
- $0
- Other
- $51,918
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $443,462
- Bonus
- $0
- Other
- $1,170
- Deferred
- $10,500
- Nontaxable benefits
- $41,418
- Filer's total
- $496,550
-
Shane CorcoranSHANE CORCORAN
SENIOR VP, STRAT. OPS. & COMMS
- Total calculated
- $473,931
- From this org
- $441,686
- From related orgs
- $0
- Other
- $32,245
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $440,516
- Bonus
- $0
- Other
- $1,170
- Deferred
- $10,500
- Nontaxable benefits
- $21,745
- Filer's total
- $473,931
-
Marko SpasicMARKO SPASIC
SR MEDICAL DIR, HEAD OF MED
- Total calculated
- $420,586
- From this org
- $398,778
- From related orgs
- $0
- Other
- $21,808
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $397,608
- Bonus
- $0
- Other
- $1,170
- Deferred
- $0
- Nontaxable benefits
- $21,808
- Filer's total
- $420,586
-
Christen DipetrilloCHRISTEN DIPETRILLO
HEAD OF INTELLECTUAL PROPERTY
- Total calculated
- $404,763
- From this org
- $330,222
- From related orgs
- $0
- Other
- $74,541
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $329,052
- Bonus
- $0
- Other
- $1,170
- Deferred
- $9,856
- Nontaxable benefits
- $64,685
- Filer's total
- $404,763
-
Sean N ParkerSEAN N PARKER
CHAIR OF THE BOARD & DIRECTOR
- Total calculated
- $0
- Hours/week
- 5 + 5 related
-
Michael PolanskyMICHAEL POLANSKY
EXECUTIVE VP & DIRECTOR
- Total calculated
- $0
- Hours/week
- 5 + 5 related
-
Tom Van Loben SelsTOM VAN LOBEN SELS
TREASURER & DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Jeffrey A Bluestone PhDJEFFREY A BLUESTONE PHD
VICE CHAIR & DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Tony Coles MDTONY COLES MD
DIRECTOR THRU 10/25
- Total calculated
- $0
- Hours/week
- 0.8
-
Eric Esrailian MD MPHERIC ESRAILIAN MD MPH
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Scott Gottlieb MDSCOTT GOTTLIEB MD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Ben HorowitzBEN HOROWITZ
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Jeff HuberJEFF HUBER
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Bob HuginBOB HUGIN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Reed JobsREED JOBS
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Bob NelsenBOB NELSEN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Bruce Parker PhDBRUCE PARKER PHD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Bob PittmanBOB PITTMAN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Ramy Ibrahim MDRAMY IBRAHIM MD
DIRECTOR THRU 10/25
- Total calculated
- $0
- Hours/week
- 0.8
-
Margo GeorgiadisMARGO GEORGIADIS
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Susan DawsonSUSAN DAWSON
SECRETARY
- Total calculated
- $0
- Hours/week
- 5 + 5 related
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 1a · First-class or charter travel
- 1b · Written policy on the line-1a expenses
- 2 · Substantiation required before reimbursing expenses
- 3 · Independent compensation consultant
- 3 · Form 990 of other organizations
- 3 · Compensation survey or study
- 3 · Approval by the board or compensation committee
- 4a · Severance or change-of-control payment
- 7 · Other non-fixed payments
Answered no
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 8 · Paid under the initial-contract exception
The filer's explanations (Part III)
- PART I, LINE 1A
- ANYONE TRAVELING OVER 3000 MILES CAN FLY BUSINESS CLASS OR FIRST CLASS (IF ONLY 2 LEVELS OF SERVICE ARE OFFERED). VP'S CAN TRAVEL BUSINESS OR FIRST CLASS FOR TRAVEL OVER 2000 MILES.
- PART I, LINE 3
- THE ORGANIZATION FOLLOWS THE PROCESS SET FORTH IN ITS BYLAWS TO REVIEW AND APPROVE THE TOTAL COMPENSATION OF ITS CHIEF EXECUTIVE OFFICER, INCLUDING SALARY, BONUS, AND BENEFITS. THE BYLAWS REQUIRE THE BOARD OF DIRECTORS OR EXECUTIVE COMMITTEE TO REVIEW ANY COMPENSATION PACKAGES, AND TO APPROVE SUCH COMPENSATION ONLY AFTER DETERMINING THAT THE COMPENSATION IS JUST AND REASONABLE. THIS REVIEW AND APPROVAL OCCURS WHEN THE CHIEF EXECUTIVE OFFICER IS HIRED, WHEN THE TERM OF EMPLOYMENT OF SUCH OFFICER IS RENEWED OR EXTENDED, AND WHEN THE COMPENSATION OF SUCH OFFICER IS MODIFIED, UNLESS THE MODIFICATION APPLIES TO SUBSTANTIALLY ALL OF THE EMPLOYEES OF THE ORGANIZATION.
- PART I, LINE 4A
- TARAK MODY RECEIVED A SEVERANCE IN THE AMOUNT OF $399,096.
- PART I, LINE 7
- MOST OF PICI'S EMPLOYMENT AGREEMENTS, WHICH ARE NEGOTIATED AT ARMS-LENGTH WITH REFERENCE TO COMPARABILITY DATA, CONTAIN A PROVISION PERMITTING ANNUAL INCENTIVE BONUSES, WHICH ARE CAPPED AT UP TO A FIXED PERCENTAGE.
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
-
$1,000,000
SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY
-
$820,714
SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY
-
$254,161
SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY
-
UNIVERSITY OF PITTSBURGH
$249,999
SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY
-
SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY
-
DANA-FARBER CANCER INSTITUTE INC
$178,420
SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY
-
THE J DAVID GLADSTONE INSTITUTES
$175,000
SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY
-
SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY
-
SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY
-
THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER
$127,267
SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY
The 10 largest by cash amount. The API serves every itemized grant.
Related organizations on this return
Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.
-
501(C)(3) · NONPROFIT SUP · CA · controlled entity
Directly controlled by PICI
-
501(C)(4) · PUBLIC INTERE · DC · controlled entity
Directly controlled by PICI
-
501(C)(4) · SOCIAL WELFAR · CA · controlled entity
Directly controlled by PICI
Taxable family on this return
Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.
Disregarded entities
Part I: entities that legally are the filer and file no return of their own.
-
MAVERIC LLC
COVID-19 CLIN · CA · income $0 · assets $0
Directly controlled by PICI
Provenance
- Return type
- form_990
- Tax year
- 2025
- Filed
- 4 August 2026
- IRS schema version
- 2025v4.2
- Source object
- 202632189349300148
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.